Search results for "erectile dysfunction"

showing 10 items of 73 documents

Extracellular Vesicles in Human Reproduction in Health and Disease.

2017

Extensive evidence suggests that the release of membrane-enclosed compartments, more commonly known as extracellular vesicles (EVs), is a potent newly identified mechanism of cell-to-cell communication both in normal physiology and in pathological conditions. This review presents evidence about the formation and release of different EVs, their definitive markers and cargo content in reproductive physiological processes, and their capacity to convey information between cells through the transfer of functional protein and genetic information to alter phenotype and function of recipient cells associated with reproductive biology. In the male reproductive tract, epididymosomes and prostasomes p…

0301 basic medicineMaleCell signalingEndocrinology Diabetes and MetabolismAcrosome reactionCell CommunicationBiology03 medical and health sciencesHuman reproductionExtracellular Vesicles0302 clinical medicineEndocrinologyErectile DysfunctionCapacitationPregnancyReproductive biologyHumansEmbryo ImplantationSperm motilityReproductionCell biologyPregnancy Complications030104 developmental biology030220 oncology & carcinogenesisOocytesSperm MotilityOviductProstasomesFemaleGenital Diseases FemaleEndocrine reviews
researchProduct

Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus

2020

Background Erectile dysfunction (ED) occurs more frequently and causes a worse response to the first-line therapies in diabetics compared with nondiabetic men. Corpus cavernosum vascular dysfunction plays a pivotal role in the occurrence of diabetes mellitus ED (DMED). The aim of this study was to investigate the protective effects of glucagon-like peptide-1 (GLP-1) analog liraglutide on ED and explore the underlying mechanisms in vivo and in vitro. Methods Type 1 diabetes was induced in rats by streptozotocin, and the apomorphine test was for screening the DMED model in diabetic rats. Then they were randomly treated with subcutaneous injections of liraglutide (0.3 mg/kg/12 h) for 4 weeks. …

0301 basic medicineautophagyRHOAerectile dysfunctionPharmacologymedicine.disease_cause03 medical and health sciences0302 clinical medicineDiabetes mellitusmedicineoxidative stressPharmacology (medical)PharmacologyliraglutideType 1 diabetesbiologybusiness.industryLiraglutidelcsh:RM1-950Autophagymedicine.diseaseStreptozotocinlcsh:Therapeutics. Pharmacology030104 developmental biologyErectile dysfunction030220 oncology & carcinogenesisdiabetes mellitusbiology.proteinbusinessOxidative stressmedicine.drugFrontiers in Pharmacology
researchProduct

Social environmental impact of Covid-19 and erectile dysfunction: an explorative review

2021

Background-\ud \ud To date, no attempt has been made to collate literature on the relationship between the social environmental impact of COVID-19 and erectile dysfunction. The aim of this explorative review was to assess and compare the prevalence of erectile dysfunction (ED) in male healthcare workers and males during the COVID-19 pandemic.\ud \ud Methods-\ud \ud A systematic review of major databases from inception to February 2021 was conducted. Prevalence data were extracted, and a random-effects meta-analysis was undertaken.\ud \ud Outcomes-\ud \ud The pooled prevalence of ED amongst healthcare workers working in COVID-19 specific environments, and non-healthcare during the COVID-19 p…

AdultMaleCoronavirus disease 2019 (COVID-19)AdolescentSexual healthEndocrinology Diabetes and MetabolismHealth PersonnelPopulationSocial EnvironmentErectile dysfunction · Sexual health · COVID-19 · PrevalenceYoung AdultEndocrinologyQuality of life (healthcare)Erectile DysfunctionEnvironmental healthHealth carePandemicPrevalenceMedicineHumansEnvironmental impact assessmentErectile dysfunctioneducationReproductive healtheducation.field_of_studybusiness.industrySARS-CoV-2COVID-19Middle Agedmedicine.diseaseErectile dysfunctionbusiness
researchProduct

Sexual Function and Quality of Life in Adult Male Individuals with Exstrophy-Epispadias Complex—a Survey of the German CURE-Network

2017

Objective To investigate sexual function and quality of life (QoL) in adult male individuals with exstrophy-epispadias complex (EEC). Data from the German Network for Congenital Urorectal Malformations (CURE-Net) were used. Patients and Methods Fifty-one male participants (≥18 years) recruited by CURE-Net between 2009 and 2012 were re-contacted per mail and asked to fill out 4 questionnaires including International Index of Erectile Function (IIEF-5), Cologne Assessment of Erectile Dysfunction (KEED), the Short-Form 36 (SF-36), and one self-designed questionnaire about their medical history, current health status, and sexual experience. The SF-36 results were compared with general German po…

AdultMalePediatricsmedicine.medical_specialtyEpispadiasUrology030232 urology & nephrologyUrinary incontinenceSubgroup analysisDiagnostic Self EvaluationYoung Adult03 medical and health sciences0302 clinical medicineErectile DysfunctionQuality of lifeGermanymedicineHumansMedical historySex organGynecologybusiness.industryPenile ErectionBladder Exstrophymedicine.diseaseBladder exstrophySexual Dysfunction PhysiologicalErectile dysfunction030220 oncology & carcinogenesisQuality of Lifemedicine.symptomSexual functionbusinessUrology
researchProduct

Sexual Health in HIV-Positive Men Under Stable Antiretroviral Therapy During a 12-Month Period

2021

Sexual health is becoming increasingly important for many HIV-positive men undergoing highly effective antiretroviral therapy (ART) but remains frequently unaddressed in routine clinical consultation.To comprehensively evaluate sexual health in male patients with HIV on stable ART over a 12-month period.The prospectively registered cohort study comprising 87 HIV-positive men on stable ART (median age: 43 years) was conducted between 2011 and 2015 at a university hospital. Patients were enrolled from the outpatient infectious disease unit and underwent an extensive andrological workup to assess parameters of sexual health (questionnaires, sex hormones, ultrasound, 2-glass urine test includin…

AdultMalePediatricsmedicine.medical_specialtySexual BehaviorUrologyEndocrinology Diabetes and MetabolismSexually Transmitted Diseases030232 urology & nephrologyHIV InfectionsCohort Studies03 medical and health sciencesSemen quality0302 clinical medicineEndocrinologyClinical endpointHumansMedicineChildReproductive health030219 obstetrics & reproductive medicinebusiness.industrymedicine.diseasePsychiatry and Mental healthSexual PartnersSexual dysfunctionErectile dysfunctionReproductive MedicineCohortSexual Healthmedicine.symptombusinessViral loadCohort studyThe Journal of Sexual Medicine
researchProduct

Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction.

1996

The therapeutic effect of the alpha 2-antagonist yohimbine in erectile dysfunction was studied in a double-blind placebo-controlled design. Thirty-one male patients underwent extensive clinical, urological, and psychiatric diagnosis and were dichotomically classified into an organic and a nonorganic subgroup. Following a 1-week placebo run-in period, patients were randomly assigned to a placebo or a verum group (yohimbine 15 mg daily) for a treatment period of 7 weeks. The Clinical Global Impression (CGI) scale was used as the primary efficacy parameter. Additionally, nocturnal penile tumescence and rigidity (NPTR) were measured. Global assessment of erectile function applying the CGI scale…

AdultMalePolysomnographyPolysomnographyPlacebolaw.inventionPlacebosAlkaloidsArts and Humanities (miscellaneous)Randomized controlled trialDouble-Blind MethodlawmedicineHumansSexual Dysfunctions PsychologicalGeneral Psychologymedicine.diagnostic_testPenile ErectionTherapeutic effectYohimbineMiddle Agedmedicine.diseaseYohimbineErectile dysfunctionAnesthesiaNocturnal penile tumescenceClinical Global ImpressionPsychologySleepmedicine.drugArchives of sexual behavior
researchProduct

Sleep investigations in erectile dysfunction

2003

Abstract Regarding the aetiology of erectile dysfunction, beside numerous organic causes in many cases psychological factors play an important role. The pathophysiological mechanisms underlying the so-called psychogenic erectile dysfunction are not yet understood. Based on a neurobiological approach to psychogenic erectile dysfunction, polysomnographic investigations were carried out with the aim of identifying possible alterations of the sleep EEG. 24 male patients with psychogenic erectile dysfunction without detectable organic factors or other mental disorders were studied in the sleep laboratory, as well as an age-matched control group without sexual dysfunctions. Beside a reduction of …

AdultMaleSleep Wake DisordersSleep StagesPolysomnographyRapid eye movement sleepElectroencephalographyMiddle AgedBioinformaticsmedicine.diseaseSleep in non-human animalsPsychiatry and Mental healthSexual dysfunctionErectile dysfunctionErectile DysfunctionmedicineHumansPsychogenic diseasemedicine.symptomSleepPsychologyNeuroscienceBiological PsychiatryDepression (differential diagnoses)Slow-wave sleepJournal of Psychiatric Research
researchProduct

Correlations between hormones, physical, and affective parameters in aging urologic outpatients.

2004

Abstract Objective: To determine the relationship between sex hormones, physical complaints, depression, sexuality, and life satisfaction in aging men. Methods: 263 outpatients aged 40 years and above ( M =56.2; 40–84 years) were recruited from 6 andrological outpatient departments in Germany to evaluate "aging male" symptoms. Subjects were assessed by standardised self-report questionnaires, physical, and endocrinological examination. Results: Total and free testosterone as well as DHEA-S (dehydroepiandrosterone-sulfate) levels decreased significantly with age. SHBG (sex hormone binding globulin) and LH (luteinizing hormone) increased; estradiol remained unchanged. Inactivity, lower urinar…

AdultMaleUrologic Diseasesmedicine.medical_specialtyAgingmedicine.drug_classUrologyPhysiologySex hormone-binding globulinLower urinary tract symptomsInternal medicineSurveys and QuestionnairesOutpatientsmedicineHumansGonadal Steroid HormonesDepression (differential diagnoses)AgedAged 80 and overbiologybusiness.industryDepressionTestosterone (patch)Middle AgedAndrogenmedicine.diseaseSexual desireErectile dysfunctionEndocrinologybiology.proteinQuality of LifebusinessLuteinizing hormoneSexualityEuropean urology
researchProduct

An interdisciplinary study towards a multiaxial classification of male sexual dysfunction

1991

The classification of male sexual dysfunction (SD) was investigated in a multidisciplinary study involving a sample of 25 outpatients whose phenomenology, course and biologic comorbidity is described. All 25 patients were suffering from arousal disorders; 9 men complained of lack of desire and 9 of orgasm disorders. For the vast majority (19/25), the arousal disorder preceded the other sexual dysfunctions. Eleven patients suffered from a psychopathological disorder according to DSM-III or DSM-III-R (Axis I and II), with general anxiety, major depression and obsessive-compulsive personality being the most common disorders. Only 6 patients were free of any organic disorder or pathological lab…

AdultMalemedicine.medical_specialtyAdolescentLibidomedia_common.quotation_subjectArousalDiagnosis DifferentialErectile DysfunctionRisk FactorsmedicineHumansPersonalityOrgasmPsychiatryPathologicalmedia_commonPatient Care TeamPsychiatric Status Rating ScalesMiddle Agedmedicine.diseasePsychophysiologic DisordersComorbidityPsychiatry and Mental healthSexual dysfunctionAnxietymedicine.symptomPsychologyAnxiety disorderPsychopathologyActa Psychiatrica Scandinavica
researchProduct

The influence of comorbidities on the aging males' symptoms scale in patients with erectile dysfunction.

2017

To investigate if certain common age-related comorbidities are related with a positive aging males' symptoms (AMS) test outcome.This was a multicentric, transversal, observational study carried out in a male population with erectile dysfunction. Comorbidities and testosterone levels were registered. The relationship between comorbidities, testosterone levels, and the AMS test outcomes was studied using the global score and the sub-scale score components.The study included 1112 patients. In the multivariate analysis the global score strongly correlated with TT  12 nmol/L (odds ratio [OR] = 3.17; p  0.05), psychiatric disorders (OR = 2.73), dyslipidemia (OR = 2.07) and diabetes mellitus (OR =…

AdultMalemedicine.medical_specialtyAgingAdolescent030232 urology & nephrologyComorbiditySensitivity and Specificity03 medical and health sciencesYoung Adult0302 clinical medicineErectile DysfunctionRisk FactorsDiabetes mellitusInternal medicineSurveys and Questionnairesmental disordersAndrogen deficiencymedicinePrevalenceHumansIn patientTestosterone030219 obstetrics & reproductive medicinebusiness.industryHypogonadismTestosterone (patch)Middle Agedmedicine.diseaseEndocrinologyErectile dysfunctionPositive agingGeriatrics and GerontologybusinessThe aging male : the official journal of the International Society for the Study of the Aging Male
researchProduct